Pharmacists in Johnston, RI Accepting Medicare

26 Pharmacists found. Showing 21 - 26

Ndeye Yacine Dabo, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1583 Atwood Ave, Johnston, RI 02919 Phone: 401-263-6438

Dr. Paul Emile Rainville, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1993 Plainfield Pike, Johnston, RI 02919 Phone: 401-942-3286

Mr. John Nawrocki, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1583 Atwood Ave, Johnston, RI 02919 Phone: 401-231-1280    Fax: 401-233-8208

Dr. Baochau H Nguyen, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1400 Hartford Ave, Johnston, RI 02919 Phone: 401-861-0310

Susan J Maciag, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1459 Atwood Ave, Johnston, RI 02919 Phone: 401-273-4470    Fax: 401-273-1820

Dr. Melanie Rose Gaspar, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1387 Plainfield St, Johnston, RI 02919 Phone: 401-942-6182

News Archive

Probability sampling to slow spread of SARS-CoV-2

Their study titled, "An Innovative Non-Pharmaceutical Intervention to Mitigate SARS-CoV02 Spread: Probability Sampling to Identify and Isolate Asymptomatic Cases," was released at the pre-publication and pre-peer review site medRxiv*.

Could the activation of FcγRIII/CD16 by anti-spike SARS-CoV-2 antibodies independently determine COVID-19 severity?

A team of scientists from Germany recently investigated whether hyperactivation of immune receptors that recognize the Fc part of an IgG molecule (FcγR) can lead to immunopathologic changes in coronavirus disease 2019 (COVID-19) patients. They have observed that hyperactivation of FcγRIII (CD16) by proinflammatory IgG antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can significantly contribute to COVID-19 related immunopathology.

DLKI-DIO3 miRNA cluster suppresses spread of cancer from its primary site

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have uncovered a group of what have been considered relatively minor regulators in the body that band together to suppress the spread of cancer from its primary site.

Obesity is associated with worse outcomes in patients with ER-positive/HER2-negative disease

Obesity was associated with worse overall and disease-free survival in women with operable breast cancer treated with adjuvant chemotherapy, but for the first time, researchers observed this finding in only a specific subset of patients - those with estrogen receptor (ER)-positive/HER2-negative disease.

Companies offer cash to employees to lose weight

Companies are betting that cash incentives will make employees want to lose weight and get healthier in other ways, The Associated Press reports. A third of companies in the U.S. offer such incentives. "Take OhioHealth, a hospital chain whose workforce is mostly overweight. The company last year embarked on a program that paid employees to wear pedometers and get paid for walking.

Read more Medical News

› Verified 6 days ago

• 1
• 2(current)